Category: antibiotics
-
STAT+: New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistance
STAT+: New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistance In a bid to mitigate antibiotic resistance, the Food and Drug Administration has released guidance for drugmakers to define how long medically important antibiotics should be used in food-producing animals. But critics argue the effort fails to consider the impact…
-
STAT+: As superbug fears grow, sales of antibiotics used in food-producing livestock rose dramatically last year
STAT+: As superbug fears grow, sales of antibiotics used in food-producing livestock rose dramatically last year Amid fears of superbugs, the sale of medically important antibiotics given to food-producing livestock rose by 16% overall in the U.S. in 2024 from the year before, an increase that prompted advocates to complain that not enough is being…
-
STAT+: What we’re hearing on Chinese NewCos, AI, and BIO’s executive ranks
STAT+: What we’re hearing on Chinese NewCos, AI, and BIO’s executive ranks This is the online version of our BIO 2025 newsletter. Get more BIO updates directly to your inbox by signing up here, and sign up for our morning biotech news roundup newsletter here. Hello everyone! Allison DeAngelis here, coming to you from Boston’s…
-
STAT+: The state of antibiotic development: ‘Deplorable comes to mind’
STAT+: The state of antibiotic development: ‘Deplorable comes to mind’ Four years ago, an ambitious pharmaceutical industry venture to tackle antibiotic resistance launched to invest in small companies that can develop two to four novel antibiotics by 2030 — and replenish the global supply chain with needed treatments. The effort began with $1 billion in backing…
-
STAT+: Lack of access to antibiotics for drug-resistant infections often blamed on poor care, study says
STAT+: Lack of access to antibiotics for drug-resistant infections often blamed on poor care, study says Only 6.9% of people with drug-resistant infections in eight large, low- and middle-income countries received an appropriate antibiotic in 2019 and the lack of access was largely attributed to insufficient care, according to a new analysis. The researchers examined…